Targeting the Integrin-Linked Kinase Pathway in Rhabdomyosarcoma
Targeting the Integrin-Linked Kinase Pathway in Rhabdomyosarcoma
批准号:
224682
负责人:
Malkin David D
金额:
$21.51万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-03-01 至 2014-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rhabdomyosarcoma (RMS) is the most common soft tissue tumor of children. It is classified into embryonal (ERMS) and alveolar (ARMS) subtypes, based on appearance under the microscope. While research has led to a greater basic understanding of how RMS tumo
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
-
批准号:478999
-
项目类别:Operating Grants
-
资助金额:$66.04万
-
财政年份:2023
-
负责人:Malkin David D
-
依托单位:
Molecular Determinants of the Li-Fraumeni Syndrome
-
批准号:313094
-
项目类别:Operating Grants
-
资助金额:$250.93万
-
财政年份:2014
-
负责人:Malkin David D
-
依托单位:
DNA Copy Number Variation in Li-Fraumeni Syndrome
-
批准号:279978
-
项目类别:Operating Grants
-
资助金额:$78.37万
-
财政年份:2013
-
负责人:Malkin David D
-
依托单位:
Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers
-
批准号:201953
-
项目类别:Operating Grants
-
资助金额:$54.54万
-
财政年份:2010
-
负责人:Malkin David D
-
依托单位:
DNA Copy Number Variation in Li-Fraumeni Syndrome
-
批准号:179254
-
项目类别:Operating Grants
-
资助金额:$56.08万
-
财政年份:2009
-
负责人:Malkin David D
-
依托单位:
海外基金